Dietary glucosamine overcomes the defects in αβ-t cell ontogeny caused by the loss of de novo hexosamine biosynthesis

HIGHLIGHTS

• who: Guy Werlen from the Ethics statement Handling and experimentation protocols for all mouse experiments have been reviewed, approved, and used in accordance with the guidelines of the Institutional Animal Care and Use Committee of Rutgers University (, and PROTO999900132) have published the research work: Dietary glucosamine overcomes the defects in u03b1u03b2-T cell ontogeny caused by the loss of de novo hexosamine biosynthesis, in the Journal: (JOURNAL) of 30/04/2022
• how: To further investigate if GFAT1 deficiency affected N-glycosylation of glycoproteins the authors conducted N-glycomics analysis by mass spectrometry. The proteomics data . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.